Aelius Biotech scientists raise £750,000 to expand overseas presence

Scientists behind laboratory gut model raise funds for further expansion

Aelius Biotech, whose laboratory gut model is used to trial new drugs without the need for animal testing has raised £750,000 from the North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia Ventures.

Aelius secures £750,000 to 'accelerate growth'

A Newcastle-based biotech company is set to expand its innovative lab testing services after raising £750,000 in funding. Aelius Biotech, founded in 2018 by Dr Peter Chater, Dr Matt Wilcox and Professor Jeff Pearson based on their research at the University of Newcastle, specialises in a unique laboratory gut model that…

Aelius Biotech scientists raise £750,000 to expand overseas presence

Aelius’s model is the only one of its type that can simulate all three stages of the digestion process – from substances passing through the gut, crossing the mucus layer on its surface and being absorbed into the body.

Aelius Biotech Raises Further £750K

Aelius Biotech, a Newcastle, UK-based biotech company providing laboratory gut models, raised £750K in funding. North East Venture Fund made the investment, supported by the European Regional Development Fund and managed by Mercia Ventures. The company intends to use the funds to expand its presence in the US and European markets and complete work on its […] The post Aelius Biotech Raises Further £750K appeared first on FinSMEs.